The alternatives
Medro scores 77/100 (grade C, ranked #66) on The Verdict Score. Here are the GLP-1 providers we'd weigh against it, scored on the same six-factor rubric. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.
This shortlist uses nearby positions in our published ranking, with our featured partner shown first. It compares program terms and features; your clinician must assess treatment suitability.
Published by The GLP-1 Verdict
Check dates vary by provider.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
CoreAge Rx scores 94/100 to Medro's 77, and our Medro vs CoreAge Rx comparison sets the two out factor by factor.
Intimate Rose is an established US women's and pelvic-health brand that has added an online weight-management program offering compounded GLP-1 medication.
Intimate Rose matches Medro at 77/100; our Intimate Rose review in full has the pricing conditions and the caveats in detail.
RestorLife Med is a physician-guided GLP-1 telehealth practice.
RestorLife Med matches Medro at 77/100; the full RestorLife Med review has the pricing conditions and the caveats in detail.
HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy.
HealthSource matches Medro at 77/100; the full HealthSource review has the pricing conditions and the caveats in detail.
Zera Health is a telehealth platform for compounded GLP-1 weight loss — semaglutide from $149/mo, tirzepatide from $199/mo, plus oral and low-dose microdose options — prescribed by licensed physicians in…
Zera Health matches Medro at 77/100; our Zera Health review in full has the pricing conditions and the caveats in detail.
Curve (Try Curve LLC) is a telehealth platform offering compounded semaglutide and tirzepatide, prescribed by Beluga Health providers licensed in all 50 states and dispensed by VialsRx, a US 503A…
Curve matches Medro at 77/100; the full Curve review has the pricing conditions and the caveats in detail.
Dose-dependent compounded injections with limited-time starting offers of $99 semaglutide and $149 tirzepatide, subject to a final clinical quote.
Ageless scores 76/100 to Medro's 77; our Ageless review in full has the pricing conditions and the caveats in detail.
See the complete rankings, the alternatives to every provider, A to Z, or head to the comparison hub.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.